Theratechnologies Inc T.TH

Fins are out..

[Steve0123]

https://www.globenewswire.com/news-release/2022/04/13/2421813/0/en/Theratechnologies-Reports-Financial-Results-for-First-Quarter-Fiscal-2022-and-Provides-Business-Update.html

[palinc2000]

Nice increase in Egrift a sales..F -8 formulation delayed for an unknown period due to a technical problem ......thus Nash trial  conveniently paused for an unknown period ...... No positive surprises in the PR

[palinc2000]

The PR shows very little enthusiasm ....Lets hope that the CC shows more life

[Wino115]

I would say it's quite positive that they are rather strongly stating they will be starting the 70+  person trial in 1H given FDA had no issues with the data provided or the plan, it becomes "FDA-approved" in two days, and recruiting is already ramping up.  That's a pretty strong statement to moving this into 1b within the next 8 weeks or so.  That will provide a

[scarlet1967]

   "We are currently exploring alternatives to redeem the senior convertible notes issued in June 2018, which become due in June 2023." I believe this is a new statement, they had about 40 millions last Q compared with 34 millions now.

[LouisW]

What does this mean? Can anyone clarify for non-financial people? Also, TH said that FDA need 30-40days to approve the amendment protocol for conducting phase2b/3 trial. Until today, it is almost 40 days, but NASH is not mentioned in the PR. Needs the progress.

[jeffm34]

European trogarzo sales down 56% from Q1 2021. How long have they been working on getting into the European market and how much has been spent?  

[palinc2000]

 We are currently exploring alternatives to redeem the senior convertible notes issued in June 2018, which become due in June 2023....... No more mention of non dilutive financing,,,,,,,,,June 2023 is very very close ....if the SP does not move substantially higher soon we are in for deep  s.....